Pharmaceuticals
GMAX Biopharm gives first does of anti-body drug treating PAH in phase 1B trial
HANGZHOU, China, Oct. 26, 2020 /PRNewswire/ -- Gmax Biopharm today announces that the first dose of GMA301 was given to the patient in its phase1B trial to investigate the drug efficacy to treat pulmonary arterial hypertension (PAH). GMA 301 is the first antibody drug for PAH treatment. In the ph...
2020-10-26 18:00
1471
Sai Life Sciences to significantly expand biology capabilities at its integrated R&D campus
HYDERABAD, India, Oct. 26, 2020 /PRNewswire/ -- Sai Life Sciences, one of
India's fastest growing Contract Research, Development & Manufacturing
Organizations
2020-10-26 16:35
2192
RhoVac Participates in BIO Europe Digital
LUND, Sweden, Oct. 26, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today that it is participating this week in the partnering event BIO Europe 2020 Digital. This week the digital version of the massive pharmaceutical partnering conference BIO Europe is held with participation from RhoVac...
2020-10-26 16:26
1499
Article on RhoVac's Phase I/II study to be published in November
LUND, Sweden, Oct. 26, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today that the publication of the article on RhoVac's Phase I/II study is set to be published in November. As previously disclosed, the article elaborating on the results of RhoVac's Phase I/II study in prostate cancer in...
2020-10-26 15:51
1433
/C O R R E C T I O N -- Azura Ophthalmics/
In the news release, Azura Ophthalmics raises $28m for registration studies for treatment of leading cause of dry eye disease, issued22-Oct-2020 by Azura Ophthalmics over PR Newswire, we are advised by the company that the [Title and the first paragraph], [the first] sentence, should read "[raise...
2020-10-23 07:16
3080
FDA Awards $1.1M Contract to CUBRC and EpiVax for Validation of New Immunoinformatic Tool for Prospective Immunogenicity Assessment of Peptide Drugs and Their Impurities
PROVIDENCE, Rhode Island, Oct. 22, 2020 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") and CUBRC, Inc. ("CUBRC") announced today that they have been awarded a two-year,$1.1 million contract from the Office of Generic Drugs (OGD) in the Center of Drug Evaluation and Research (CDER) of the Food and Drug ...
2020-10-22 21:00
2519
Connect Biopharma to Present Additional Positive Results from the Phase 1b Study of CBP-201 for Patients with Moderate-to-Severe Atopic Dermatitis (AD) at EADV Virtual Meeting
SAN DIEGO and TAICANG, SUZHOU, China, Oct. 22, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune and inflammatory diseases, today announced it wil...
2020-10-22 19:30
1765
Sihuan Pharmaceutical's Gabapentin Capsules was Granted Drug Production Approval, the Third Company Obtained Approval in China
HONG KONG, Oct. 22, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd.(the "Company'' or ''Sihuan Pharmaceutical'', together with its subsidiaries, the ''Group''; HKEX stock code: 0460) is pleased to announce that the National Medical Products Administration has granted drug productio...
2020-10-22 10:36
10934
Priority Review Granted to Ascentage Pharma's New Drug Application for Olverembatinib (HQP1351), the First Third-Generation BCR-ABL Inhibitor in China
SUZHOU, China and ROCKVILLE, Md., Oct. 21, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Center for Drug Eva...
2020-10-21 17:37
2287
Cyclica to use Excelra's GOSTAR Database to develop AI & ML based Deep Learning Algorithm for Drug Target Identification
HYDERABAD, India and TORONTO, Oct. 21, 2020 /PRNewswire/ -- Excelra
2020-10-21 10:00
4618
One broken bone leads to another, warns IOF on World Osteoporosis Day
NYON, Switzerland, Oct. 21, 2020 /PRNewswire/ -- Today, the International Osteoporosis Foundation (IOF) calls for all adults to be alert to their risk factors for osteoporosis, a disease which can lead to a dangerous, life-threatening spiral of broken bones. A broken bone (known as a fracture) w...
2020-10-21 06:18
3375
Nanoform initiates GMP campaign for first-in-human trial of nanoformed drug by year end - ahead of schedule
HELSINKI, Finland, Oct. 21, 2020 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform "), an innovative nanoparticle medicine enabling company will, in the fourth quarter of 2020, start the first ever human trial of a drug candidate nanoformed using Nanoform's proprietary CESS® technology. Dosing will ...
2020-10-21 02:14
4267
Key patent granted for Isla101 in Brazil
MELBOURNE, Australia, Oct. 20, 2020 /PRNewswire/ -- Isla Pharmaceuticals, a US-based company focused on rational repurposing of molecules for the treatment or prevention of viruses is pleased to announce that a key patent relating to the Company's lead program, Isla101 has been granted by the Bra...
2020-10-20 03:15
2002
Over One Thousand Psychiatrists Gather Online for Second Asia Pacific Psychiatry Symposium
SHANGHAI, Oct. 19, 2020 /PRNewswire/ -- The Second Asia Pacific Psychiatry Symposium hosted by Luye Pharma Group took place as an online event onOctober 17, 2020. More than 1,000 psychiatrists and experts from 9 countries and regions including mainlandChina, Malaysia, Korea, Singapore, and Thaila...
2020-10-19 17:46
4232
Xinhua Silk Road: The 51st Zhangshu National TCM Materials and Pharmaceuticals Trade Fair kicked off in the eastern Chinese city of Zhangshu
BEIJING, Oct. 19, 2020 /PRNewswire/ -- The 51st Zhangshu National TCM Materials
and Pharmaceuticals Trade Fair sponsored by the China Association of
Traditional Chinese Medicine opened in Zhangshu, a country-level city in east
China's Jiangxi Province on Friday.
2020-10-19 17:41
2662
Picosun's success brings Chairman of the Board Kustaa Poutiainen the National Entrepreneur Award of Finland 2020
ESPOO, Finland, Oct. 19, 2020 /PRNewswire/ -- The Chairman of the Board and founder of Picosun Group, Mr. Kustaa Poutiainen, has been awarded asFinland's Entrepreneur of the Year 2020. Mr. Poutiainen received the National Entrepreneur Award in the annual meeting of the Federation of Finnish Ente...
2020-10-19 10:03
2206
111, Inc. Teams Up with Huluwa Pharmaceutical to Explore the New Domain of "Internet + pharmaceutical"
SHANGHAI, Oct. 15, 2020 /PRNewswire/ -- On September 24, 111, Inc. (NASDAQ: YI) (the "Company" or "111") and Hainan Huluwa Pharmaceutical Group Co., Ltd. (SH: 605199) ("Huluwa Pharmaceutical") signed a strategic partnership agreement in Shanghai. Mrs. LIU Jingping, Chairperson of Huluwa Pharmace...
2020-10-16 05:40
16352
111 to be the Omni-channel Drug Commercialization Partner of Xiangxu Pharmaceutical for Traditional Chinese Medicine
SHANGHAI, Oct. 15, 2020 /PRNewswire/ -- On September 24, 111, Inc. (the "Company" or "111") and Guangzhou Xiangxue Pharmaceutical Co., Ltd. ("Xiangxue Pharmaceutical") officially signed a strategic partnership agreement (the "Agreement") to deepen collaboration to further develop the "Internet + ...
2020-10-16 05:35
14983
Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
MECHELEN, Belgium and PARIS, Oct. 16, 2020 /PRNewswire/ -- Servier and Galapagos NV report that no signal of activity was observed in the topline results in their ROCCELLA Phase 2 trial with GLPG1972/S201086. ROCCELLA is a global, double-blind, placebo-controlled, dose ranging trial evaluating t...
2020-10-16 05:09
2859
Insilico partners with Taisho on end-to-end AI-powered senolytic drug discovery
HONG KONG, Oct. 15, 2020 /PRNewswire/ -- Insilico Medicine announced today that Taisho Pharmaceutical Co., Ltd. and Insilico have entered into a research collaboration to identify novel therapeutics against aging. Insilico Medicine will utilize both the target discovery and generative chemistry p...
2020-10-15 21:00
4480
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
7120
